News - MedTech & Diagnostics
Department of Health halts PL changes as industry warns of device viability
The Department of Health has received the final evaluation report into the Prescribed List (PL) reforms from the Nous Group, […]
MoreNews - MedTech & Diagnostics
The missing 51%: Healthcare’s market failure may be its biggest opportunity
The persistent gender health gap represents both a market failure and a significant capital allocation opportunity, according to a new […]
MoreNews - MedTech & Diagnostics
Government’s BreastScreen funding contradicts Review, leaving a major reform gap
The federal government has released the long-awaited BreastScreen Australia Review report more than 1,000 days after it was first commissioned. […]
MoreNews - MedTech & Diagnostics
Senate scrutiny underway as states oppose federal policy on health insurance rebate cuts
The Federal Government is facing mounting criticism over proposed reductions to the private health insurance rebate for Australians over the […]
MoreNews - MedTech & Diagnostics
Diabetes experts set minimum CGM standards to address controversial media coverage
Australian and New Zealand diabetes experts have published minimum performance standards for continuous glucose monitoring (CGM) devices, following the controversial […]
MoreNews - MedTech & Diagnostics
Alzheimer’s Centre marks new era but patient access hits construction zone
Federal Health Minister Mark Butler has officially opened the Asia Pacific Centre of Excellence for Alzheimer’s Diagnosis, a collaboration between […]
MoreNews - MedTech & Diagnostics
First integrated kidney centre sets new benchmark
Patients across Sydney are set to benefit from the first centre in the state to offer a fully integrated model […]
MoreNews - MedTech & Diagnostics
Aussie medtech secures TGA approval for advanced lung imaging technology
ASX-listed medtech company 4DMedical has secured Therapeutic Goods Administration (TGA) approval for its respiratory imaging technology, clearing the way for […]
MoreNews - MedTech & Diagnostics
Researchers, diagnostics and pharma unite on Alzheimer’s blueprint
A new alliance is set to to rewrite the future of Alzheimer’s care in Australia, bringing together researchers with the […]
MoreNews - MedTech & Diagnostics
Calls for chronic pain to be seen, counted and treated
The Faculty of Pain Medicine (FPM) of the Australian and New Zealand College of Anaesthetists (ANZCA) has welcomed the release […]
MoreRecent Posts in Pharma, MedTech & Biotech
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
August 7, 2026
in News - MedTech & Diagnostics
Department of Health halts PL changes as industry warns of device viability
August 7, 2026
in News - MedTech & Diagnostics
argenx inks new agreement with Australian regenerative medicine biotech
August 7, 2026
in News - Biotechnology
The human face rewriting Australia’s most common rare disease, cystic fibrosis
August 7, 2026
in News - Pharmaceuticals
‘We must transcend silos in service of patients,’ says AbbVie VP & GM
August 6, 2026
in News - Pharmaceuticals
The missing 51%: Healthcare’s market failure may be its biggest opportunity
August 6, 2026
in News - MedTech & Diagnostics
Government’s BreastScreen funding contradicts Review, leaving a major reform gap
August 6, 2026
in News - MedTech & Diagnostics
Senate scrutiny underway as states oppose federal policy on health insurance rebate cuts
August 4, 2026
in News - MedTech & Diagnostics
Follow Us
Partner with us
News - MedTech & Diagnostics
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
The leadership compass is being recalibrated as the old coordinates give way to complexity, contradiction and change. For Liz Carnabuci, […]
MoreNews - MedTech & Diagnostics
Department of Health halts PL changes as industry warns of device viability
The Department of Health has received the final evaluation report into the Prescribed List (PL) reforms from the Nous Group, […]
MoreNews - Biotechnology
argenx inks new agreement with Australian regenerative medicine biotech
Immunology company argenx has entered into a new strategic partnership agreement with Monash University and Monash-originated spinout Myostellar, to develop […]
MoreNews - Pharmaceuticals
The human face rewriting Australia’s most common rare disease, cystic fibrosis
New national data from the Australian Cystic Fibrosis Data Registry (ACFDR) has revealed a significant shift in the trajectory of […]
More